Compare PGEN & PSNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PGEN | PSNY |
|---|---|---|
| Founded | 1998 | 2017 |
| Country | United States | Sweden |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Auto Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2013 | N/A |
| Metric | PGEN | PSNY |
|---|---|---|
| Price | $4.12 | $19.09 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 5 | 2 |
| Target Price | $8.33 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 2.8M | 75.4K |
| Earning Date | 05-13-2026 | 04-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $230,981,000.00 | N/A |
| Revenue This Year | $1,115.92 | $31.06 |
| Revenue Next Year | $81.04 | $47.98 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.23 | $0.50 |
| 52 Week High | $5.47 | $23.28 |
| Indicator | PGEN | PSNY |
|---|---|---|
| Relative Strength Index (RSI) | 54.94 | 53.99 |
| Support Level | $3.91 | $15.55 |
| Resistance Level | $4.31 | $22.75 |
| Average True Range (ATR) | 0.19 | 1.16 |
| MACD | 0.00 | -0.09 |
| Stochastic Oscillator | 64.01 | 41.43 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.